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In Graves’ disease (GD) the presence of antibodies to the thyroid stimulating hormone (TSH) receptor leads to stimula- 
tion of the thyroid gland. The thyroid stimulating activity of Graves’ IgG is normally ascertained by bioassays measuring 
CAMP production. We have investigated the effect of Graves’ IgG on the quantitative activation of thyroglobulin (TG) 
gene in cultured human thyroid cells by RNA’ hybridisation. TG mRNA expression was activated by TSH and Graves’ 
IgG. Nuclear transcription assays howed that the increase in cytoplasmic mRNA levels was due to increased transcrip- 
tion of TG specific mRNA in nuclei of thyroid cells. Whilst TSH led to a dose dependent increase in TG mRNA levels, 
Graves’ IgG led to a variable activation of TG gene. A significant correlation between the increased TG mRNA transcrip- 
tion and CAMP production was observed with Graves’ IgG. Thus the activation of the TG gene by Graves’ IgG occurs 
in parallel with elevation of CAMP. 
Thyroid autoimmunity; Graves’ disease; Immunoglobulin G; Thyroglobulin; mRNA 
1. INTRODUCTION 
Thyroid stimulating hormone (TSH) plays a cen- 
tral role in regulating the activity of the thyroid 
follicular cells. In particular, the TSH-induced 
release of thyroid hormone is mediated by cyclic 
AMP (CAMP) which has been shown to modulate 
the activity of the thyroglobulin (TG) gene [l]. 
Thus agents which activate the CAMP system or 
derivatives of CAMP can mimic the effect of TSH 
on TG gene expression in vitro using rat [2,3] and 
human [4] thyrocytes. 
In Graves’ disease (GD), autoantibodies (aAbs) 
to the TSH receptor can lead to marked stimula- 
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tion of the gland and therefore hyperthyroidism in 
autoimmune thyroid disease (AITD) [5]. There is 
recent evidence that Graves’ IgG in vitro leads to 
the release of TG by cultured human thyroid cells 
and this stimulation of TG expression correlates 
with TSH activity [6]. In this study, using cultured 
human thyroid cells, we have examined the rela- 
tionship between TG gene activation at the nuclear 
and cytoplasmic level by hybridisation studies us- 
ing slot blot techniques and the release of CAMP as 
assessed by bioassay in response to TSH and 
Graves’ IgG. 
2. MATERIALS AND METHODS 
2.1. Patients’ sera 
Serum samples were obtained from 22 patients with AITD. 
Two sera were from Hashimoto’s thyroiditis patients, whilst the 
remainder were from GD patients. All patients had clinical and 
biochemical evidence of hyperthyroidism prior to treatment, a 
diffusely enlarged thyroid gland and diffuse uptake of radioac- 
tivity on thyroid scan. Normal sera (n = 20) were obtained from 
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individuals with no history of thyroid disease. Sera were 
precipitated with ammonium sulphate and the immunoglobulin 
dialysed overnight against phosphate buffered saline, pH 7.4, 
filter sterilized and stored at 3.0 mg/ml at -20°C. 
2.2. Culture of human thyroid cells 
Thyroid tissue from a Graves’ patient removed at partial 
thyroidectomy was used and after collagenase dispersion 
prepared for cryopreservation as described [7]. For in vitro 
stimulation of thyrocytes, thyroid cells were rapidly thawed at 
37°C and grown overnight o allow cells to form a monolayer 
in RPM1 1640 + 10% fetal calf serum. For measurement of TG 
gene transcription or CAMP levels approximately lo6 or 10’ 
cells in 500 pl medium, respectively, for each assay were added 
to the wells of a 24-well costar plate. At this point bovine TSH 
(bTSH, Armour) or Graves’ IgG was added to triplicate wells 
and incubated for 4 h at 37°C. At the end of incubation, the 
culture medium was removed, the cells washed once and then 
prepared for RNA extraction or CAMP release. In other ex- 
periments forskolin or 12-0-tetradecanoyl phorbol 13-acetate 
(TPA) were used also. 
2.3. Total RNA extraction 
The single-step acid guanidinium-phenol-chloroform ethod 
was used to isolate the total cellular RNA [8]. 
2.4. RNA slot blot analysis and hybridizafion 
The RNA was transferred to Gene Screen Plus membrane 
(NEN) using a slot blot apparatus (Schleicher and Schuell). 
Prehybridization and hybridization were performed ac- 
cording to the manufacturer’s instructions. Plasmid cDNA 
probes to human TG (M4 probe) [9] or chicken brain &actin 
(pA1 probe) [lo] were labelled by nick translation to a specific 
activity of l-2 x 10s cpm/pg. Hybridization to ,&actin cDNA 
probe was performed to normalise the amount of total RNA 
applied to each slot as described [1 11. Following 
autoradiography with the TG probe, the membrane was strip- 
ped of the labelled probe, autoradiographed to confirm probe 
removal and the membrane then rehybridized with nick 
translated @actin probe. The hybridization signal was ascer- 
tained by scanning densitometry in a Shimadzu instrument. For 
quantification, the density of each band on the ,&actin probe 
blot was expressed as a ratio of an arbitrarily selected band on 
the same autoradiograph and this ratio was used to calculate the 
corrected values for the density of the corresponding band on 
the TG-probed blot [1 I]. The levels of fi-actin mRNA did not 
change following stimulation with TSH or Graves’ IgG (not 
shown). 
2.5. Nuclear runoff transcription assay 
This was performed by isolating nuclei from human thyroid 
cells grown in monolayers in the presence or absence of TSH as 
in [12]. Briefly, nuclei were prepared from the cells following 
trypsinisation (approx. 5 x ld viable, isolated thyrocytes) by 
vortexing the cells gently in 0.5% NP40. Nuclei were incubated 
for 30 min at 37°C with 500&i “P-UTP (3000 Ci/mmol) 
followed by purification of the 3zP-labelled RNA transcripts 
[ 131. For hybridization, 8.5 pg of linearised plasmid containing 
the TG or chicken .&actin cDNA were applied to Gene Screen 
Plus membrane in the slot blot apparatus and prehybridization 
and hybridization performed exactly as described [14]. As a 
control, linearized pBR322 was applied to the membrane. Ap- 
proximately 3 x lo6 cpm of runoff products in 1 ml hybridiza- 
tion buffer was applied per filter for nuclei from both the TSH 
stimulated and unstimulated thyrocytes. Following hybridiza- 
tion, background was reduced by treatment of the filters with 
RNase A [14] and the filters exposed to Hyperfilm-MP (Amer- 
sham International Plc) at - 70°C. 
2.6. CAMP assay 
CAMP was measured using a modified procedure as described 
1151. 
3. RESULTS 
3.1. Effect of TSH on TG gene activation 
Increasing concentrations of TSH produced a 
dose-response stimulation of TG gene activation in 
human thyroid cells in vitro. At a maximum TSH 
concentration of 100 mu/ml, an 115.8 + 45.6% 
30 
25 
TSH (mlJ / ml) 
Fig. 1. Effect of different concentrations of TSH on 
transcription of TG mRNA in cultured human thyroid cells. 
Cultures were exposed to TSH for 4 h. The TG mRNA was 
quantitated by densitometric scanning of total RNA with nick 
translated TG probe and normalizing with respect to signal 
from @actin probe. The results are derived from three separate 
experiments. 
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(mean + SD) increase in TG mRNA transcripts 
was apparent compared to cells cultured in the 
absence of the hormone (fig.1). This stimulatory 
effect of TSH was obtained 2 h following addition 
of the hormone and persisted for at least 48 h in 
the presence of 10 mu/ml TSH (fig.2A). 
Withdrawal of TSH from the culture medium led 
to a 50% decrease in TG mRNA levels after 5 days 
which following restimulation of the cells with 
TSH readily restored transcription rates of the TG 
gene to comparable levels (fig.2B). When TSH was 
substituted either with forskolin (10e5 M) or TPA 
( low7 M) an increase in TG mRNA levels of 85.1 + 
39% and 52.8 + 16.8%, respectively, was ap- 
parent. Elevation in CAMP levels with increasing 
dose of TSH was also observed (not shown). 
3.2. TG mRNA is regulated transcriptionally by 
TSH 
In order to determine whether the cytoplasmic 
TG mRNA increase observed with TSH was due to 
activation of the TG gene or changes in degrada- 
160 
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Fig.3. Nuclear runoff transcription assay on nuclei prepared 
from primary human thyroid cell cultures in the absence (T = 
0) or presence of TSH (10 mU/ml) for 4 h (T = 4). ‘*P-UTP 
labelled transcribed RNA was purified and hybridised to 
linearised plasmids: (1) EcoRI digested M4 plasmid containing 
1260 bp TG cDNA in pBR322; (2) EcoRI digested pA1 plasmid 
containing 2100 bp chicken brain /3-actin cDNA in pBR322; (3) 
EcoRI digested pBR322 plasmid as control. 
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tion of cytoplasmic mRNA, nuclear runoff 
transcription assays were performed. TSH induced 
approximately a 7-fold increase in TG gene 
transcription rate within 4 h compared to cells 
cultured in the absence of the hormone (fig.3). 
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Fig.2. Effect of time on TG mRNA transcription following stimulation of cultured human thyroid cells with TSH. (A) Cells exposed 
to 10 mu/ml TSH (0) or cultured in the absence of the hormone (0). (B) Cells cultured in the absence of TSH for 5 days before 
addition of 10 mu/ml TSH (a) or cultured without the hormone (0). 
14 
Volume 232, number 1 FEBS LETTERS May 1988 
Fig.4. RNA slot blot analysis from human thyroid cells treated with Graves’ IgG for 4 h. The figure shows the effect of 4 different 
sera from patients with Graves’ disease (Pl, P2, P3 and P4) in comparison to the effect of IgG preparation from a pool of 20 sera 
from normal individuals (NHS). The slots were hybridized with nick translated TG probe, exposed for autoradiography (4 days) 
dehybridized and exposed to nick translated ,f-actin probe for autoradiography (1 day). 
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Fig.5. Correlation of transcription of TG mRNA in comparison 
to CAMP release following treatment of human thyroid cells 
with Graves’ IgG preparations from 22 patients and pooled 
normal human sera. 
This demonstrates that TSH effects the TG gene 
expression at the nuclear level. Actin transcription 
did not change with TSH stimulation (fig.3). 
3.3. Effect of immunoglobulin from Graves’ 
disease patients on TG gene activation 
Immunoglobulin preparations from the sera of 
Graves’ disease patients produced variable levels 
of TG gene activation after 4 h incubation which 
was not observed with pooled sera from normal in- 
dividuals (fig.4). When compared to the CAMP in- 
crease with the Graves’ IgG preparations, a highly 
significant correlation was obtained (r = 0.6779, 
p < 0.001) between the levels of TG gene activa- 
tion and CAMP release, suggesting that CAMP was 
intimately involved in the stimulatory activity of 
the Ig preparations (fig.5). 
4. DISCUSSION 
Our results show that TSH produces a dose 
dependent increase in TG mRNA levels in cultured 
human thyroid cells. Whilst a several fold increase 
in TG specific RNA transcripts was apparent in the 
nuclei, the elevation in cytoplasmic TG mRNA 
levels was approximately 2-fold, which may thus 
indicate increased egradation of the TG mRNA in 
the cytoplasm following transcription. The parallel 
increase in the release of CAMP from these cells in 
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response to TSH suggests that CAMP acts as the 
physiological mediator of the TSH induced activa- 
tion of the TG gene in human thyrocytes. These 
findings are supported by the effect of forskolin, 
an activator of the adenylate cyclase system which 
mimicked the effect of TSH on TG mRNA induc- 
tion. Comparable observations in vitro also show 
that an increase in serum TG levels can be related 
to the TSH dose administered in humans [ 161. Our 
findings contrast with the RNA hybridisation 
studies by Chebath et al. [17] where maximum TG 
levels reach a plateau at 0.05 mu/ml TSH in por- 
cine thyroid cell cultures. Patients with hyper- 
thyroid Graves’ disease have elevated serum levels 
of TG which return into the normal range once 
euthyroidism is achieved with antithyroid treat- 
ment [ 181. Thyroglobulin levels have been shown 
to correlate with TSH receptor antibody activity in 
vitro [7]. We now demonstrate a significant cor- 
relation between the activation of TG gene expres- 
sion and the level of TSH receptor antibody 
activity as assessed by the generation of CAMP in 
a human thyroid cell bioassay. The ability to assess 
the thyroid cell functional response to TSH recep- 
tor antibody has always been limited by the inap- 
propriateness of measuring release of total TG (the 
levels of which are also regulated by other factors) 
and the difficulty of measuring levels of thyroid 
hormone in tissue culture supernatants. Indirect 
measures of parameters uch as receptor binding, 
CAMP generation, iodine uptake and colloid 
droplet formation give only limited and indirect in- 
formation on the thyroid synthetic capacity. The 
demonstration of TG mRNA stimulation by TSH 
receptor antibody and their correlation with CAMP 
synthesis uggests amore direct measure of thyroid 
cell stimulation. The fact that the correlation is in- 
complete opens avenues for further investigation 
of other second messenger routes to the activation 
of the TG gene. 
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